Bloomberg Baystate Business Hour: Precision Medicine

Back Bay Life Science Advisors CEO Jonathan Gertler joined anchor Anne Mostue on The Bloomberg Baystate Business Hour to discuss Convergence Forum, the annual ideas exchange on the future of healthcare from biotech leaders around greater New England.

On May 11, Dr. Gertler will host a Convergence Form panel discussion on corporate strategy and precision medicine with Sobi CEO  Geoffrey McDonough, MD and Harvard University Professor of Computational Biology and Bioinformatics John Quackenbush, PhD.

Dr. Gertler noted that “The more precise we want to get scientifically, the harder it is to translate to our healthcare delivery system.” This translation in the long run will have a huge impact on how we treat disease. The precision medicine panel will be a conversation around the science, what companies can do to prepare for long-term growth with precision medicine and how best to meet their responsibility to patients.

The Bloomberg interview can be found at this link.

Back Bay will share learnings from Convergence Forum and thoughts on corporate strategy and precision medicine in our May newsletter.